Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_700ff9a01db2075489cb7ed87392dc28 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14532 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-005 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02 |
filingDate |
1993-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2000-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64a3289e46d58aa686d7b0332774bbad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62d3a3f1484bd1f6fcbf92240d581a2b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caad4443fed77189c5ea96bfc1ed5cf8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a5817eda33306d03df51e462227a62d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79428aa9e628d0fd06ebbe501ce9fc0c |
publicationDate |
2000-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0633755-B1 |
titleOfInvention |
Systems for cells implants |
abstract |
A method for implanting cells is disclosed which employs a chamber having a wall forming porous boundary between the host and implanted cells. According to the method, a given number of cells (N) is placed within the porous boundary of a given area (A) such that the quantity A/N is less than about 200 mu m2/cell. The porous boundary has a pore size, an ultimate strength, and a metabolic transit value that assures the survival of the cells during the critical ischemic period and afterward. |
priorityDate |
1992-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |